Celgene Corporation (CELGZ)
-NasdaqGM 7.25 
0.04(0.55%) 9:51AM EDT - Nasdaq Real Time Price
| Prev Close: | 7.29 |
|---|
| Open: | 7.38 |
|---|
| Bid: | 7.25 x 100 |
|---|
| Ask: | 7.40 x 100 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 7.08 - 7.38 |
|---|
| 52wk Range: | 1.62 - 7.95 |
|---|
| Volume: | 1,800 |
|---|
| Avg Vol (3m): | 14,771 |
|---|
| Market Cap: | N/A |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | N/A |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Celgene Corporation discovers, develops, and commercializes innovative therapies to treat cancer and immune-inflammatory diseases in the United States, Europe, and internationally.
View More